行情中心升级到1.1版! 官方博客

基金业绩

基金费率

投资组合

基金概况

财务数据

中信建投医改A(002408)

2025-05-19     1.54230.4690%
十大重仓股
截止日期:  
 查询其他基金该项数据
报表日期2025-03-31
序号 证券代码 证券简称 市值(万元) 数量(万股) 占基金净值比例(%) 其它基金持有(家)
1603259药明康德11,781.00175.009.90627
2688266泽璟制药9,974.00100.008.38302
3688192迪哲医药9,800.00200.008.2383
4603127昭衍新药8,136.00400.006.8435
5002821凯莱英7,875.00100.006.6266
6300436广生堂7,477.30230.006.288
7301101明月镜片7,253.82135.016.0915
8300759康龙化成7,133.80265.005.99113
9688578艾力斯6,397.5075.005.37139
10300363博腾股份6,160.00350.005.1819
报表日期2024-12-31
序号 证券代码 证券简称 市值(万元) 数量(万股) 占基金净值比例(%) 其它基金持有(家)
1603259药明康德11,833.60215.0010.001690
2688351微电生理9,520.00500.008.04305
3688192迪哲医药8,294.00200.007.01468
4002821凯莱英7,609.00100.006.43512
5300436广生堂7,514.10230.006.3528
6603456九洲药业6,840.00500.005.78262
7688266泽璟制药6,231.00100.005.26690
8300633开立医疗5,878.00200.004.97546
9300759康龙化成5,782.50225.004.88768
10300363博腾股份5,519.50350.004.66275
报表日期2024-09-30
序号 证券代码 证券简称 市值(万元) 数量(万股) 占基金净值比例(%) 其它基金持有(家)
1603259药明康德11,833.60215.0010.001690
2688351微电生理9,520.00500.008.04305
3688192迪哲医药8,294.00200.007.01468
4002821凯莱英7,609.00100.006.43512
5300436广生堂7,514.10230.006.3528
6603456九洲药业6,840.00500.005.78262
7688266泽璟制药6,231.00100.005.26690
8300633开立医疗5,878.00200.004.97546
9300759康龙化成5,782.50225.004.88768
10300363博腾股份5,519.50350.004.66275